US HB413 | 2013-2014 | 113th Congress

US Congress House Bill 413 (Prior Session Legislation)

Status

Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on January 23 2013 - 25% progression, died in committee
Action: 2013-02-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Amends the American Taxpayer Relief Act of 2012 to eliminate the two-year delay (until January 1, 2016) of the authority of the Secretary of Health and Human Services (HHS) to implement oral-only End Stage Renal Disease (ESRD)-related drugs in the ESRD prospective payment system (PPS) under title XVIII (Medicare) of the Social Security Act. (Thus authorizes the Secretary to implement such drugs in the ESRD-PPS immediately.)

Title

To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.

History

Date	Chamber	Action
2013-02-08	House	Referred to the Subcommittee on Health.
2013-01-25	House	Referred to the Subcommittee on Health.
2013-01-23	House	Referred to House Ways and Means
2013-01-23	House	Referred to House Energy and Commerce
2013-01-23	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.